QA: Pardes Biosciences INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001822711_2023_Pardes_Biosciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001822711, Pardes Biosciences INC

  xvar xval
0 AssetsCurrent 200,402,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 219,000
4 LiabilitiesCurrent 20,425,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,467,000
9 ResearchAndDevelopmentExpense 70,350,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,183,000
13 remainder_ComprehensiveNetIncome -24,000
  yvar yval
0 Assets 200,621,000
1 Liabilities 20,425,000
2 Expenses 99,817,000
3 Revenues 0
4 StockholdersEquity 180,196,000
5 NetIncome -96,634,000
6 ComprehensiveNetIncome -96,646,000
7 BaseVar 162,035,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.68
9 EconomicCapitalRatio 3.47

Edgar->Model Mapping

Feature Distribution

Change over Time